Recent Finacing
Recent Raise
Galenea develops MANTRA, a high-throughput platform for measuring synaptic transmission in rodent primary and human iPSC-derived neurons, and uses it to characterize synaptic dysfunction and discover pro-cognitive CNS therapeutics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors